Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 11-2021 | 09-2021 | 08-2021 | 06-2021 | |
Operating Expenses | 0 | 2,552 | 2,245 | 0 | 2,254 |
Operating Income | N/A | -2,552 | -2,245 | N/A | -2,254 |
Interest Expense | 0 | 1 | 0 | 0 | 0 |
Other Income | 0 | 3 | 0 | 0 | 2 |
Pre-tax Income | 0 | -2,550 | -2,245 | 0 | -2,252 |
Net Income Continuous | N/A | -2,550 | -2,245 | N/A | -2,252 |
Net Income | $N/A | $-2,550 | $-2,245 | $N/A | $-2,252 |
EPS Basic Total Ops | N/A | -1.20 | -1.37 | N/A | -1.50 |
EPS Basic Continuous Ops | N/A | -1.26 | -1.37 | N/A | -1.44 |
EPS Diluted Total Ops | N/A | -1.20 | -1.37 | N/A | -1.50 |
EPS Diluted Continuous Ops | N/A | -1.26 | -1.37 | N/A | -1.44 |
EBITDA(a) | $N/A | $-2,552 | $-2,245 | $N/A | $-2,254 |